Platelet Inhibition in Patients With Systolic Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 15, 2013

Primary Completion Date

December 1, 2015

Study Completion Date

December 28, 2015

Conditions
Systolic Heart Failure
Interventions
DRUG

Prasugrel 10 mg daily x 2 weeks

DRUG

Clopidogrel 75 mg daily x 2 weeks

Trial Locations (1)

68198

University of Nebaska Medical Center, Omaha

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Daiichi Sankyo

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Nebraska

OTHER